Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Real world outcomes with <scp>Bortezomib Thalidomide dexamethasone</scp> and <scp>Cyclophosphamide Bortezomib dexamethasone</scp> induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple

PaperCitations, authors & open-access status

Real world outcomes with <scp>Bortezomib Thalidomide dexamethasone</scp> and <scp>Cyclophosphamide Bortezomib dexamethasone</scp> induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 10 citations, 2020 year and closed oa status.

10
Citations
2020
Year
closed
OA Status

Related on ScholarIQ

Patricio Duarte
Author
Multiple Myeloma Research and Treatments
Topic
Multiple Myeloma Research and Treatments
Topic
Cancer Treatment and Pharmacology
Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Topic
470M+ articles · free account